Project Description
Luoda has developed a combination product with antibacterial, antifungal and anti-inflammatory activity which is administered as a single long acting application into the canine external ear canal under light sedation by a veterinarian. This eliminates the need for application to the ear 2-3 times a day, increasing the likelihood of therapeutic success in this notoriously difficult to treat condition.
Target
Otitis externa (infection of the external ear canal) in dogs
Project Details
| Development Status: | Clinical Development Ongoing |
| Licence Status: | Pharma company partner being sought |
| Commercialisation Date: | Estimated 2019 |